EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC-ND 4.0

Effect of midazolam co-administered with oxycodone on ventilation: a randomised clinical trial in healthy volunteers

Victoria Gershuny, Jeffry Florian, Rutger van der Schrier, Michael C Davis, Pablo Salcedo, Celine Wang, Keith Burkhart, Kristin Prentice, Aanchal Shah, Rebecca Racz, Vikram Patel, Murali Matta und 8 weitere

British Journal of Anaesthesia · 2025

DOI: 10.1016/j.bja.2024.11.047 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift British Journal of Anaesthesia, 2025. Verfasst von Victoria Gershuny und 19 weiteren Autor:innen. Beteiligte Einrichtung: Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, U…. Hauptthemen laut MEDLINE: Oxycodone, Midazolam, Analgesics, Opioid, Hypnotics and Sedatives. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Oak Ridge Institute for Science and Education, US Food and Drug Administration.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: Benzodiazepines can exacerbate opioid-induced respiratory depression by furthering the decrease in central respiratory drive and causing loss of upper airway patency potentially leading to airway obstruction. This study aimed to determine if co-administration of benzodiazepines and opioids significantly decreases hypercapnic ventilation compared with opioids alone. METHODS: We conducted a randomised, double-blind, four-period crossover trial in 20 healthy participants to assess whether i.v. midazolam (0.0375 mg kg-1 in the first five participants; 0.075 mg kg-1 in 15 participants) plus oral oxycodone (10 mg), compared with oxycodone alone, decreases minute ventilation at an end-tidal carbon dioxide (Pco2) of 7.3 kPa using modified Read rebreathing methodology. RESULTS: Midazolam administered with oxycodone, compared with oxycodone alone, did not significantly decrease minute ventilation at an end-tidal Pco2 of 7.3 kPa (23.5 vs 25.2 L min-1; mean difference -1.7 L min-1, one-sided 95% confidence interval -∞ to 1.6; P=0.21). However, midazolam plus oxycodone increased resting end-tidal Pco2 compared with oxycodone alone (5.8 vs 5.6 kPa; mean difference 0.2 kPa, 95% confidence interval 0.0-0.4). Nine of 15 (60%) participants fell asleep or snored on midazolam plus oxycodone, compared with 0 of 15 (0%) on oxycodone alone. CONCLUSIONS: Midazolam co-administered with oxycodone did not decrease hypercapnic ventilation, compared with oxycodone alone, but did affect tidal volume, ventilatory frequency, and resting end-tidal Pco2. These findings support the hypothesis that benzodiazepines influence ventilation by inducing relaxation of the respiratory muscles and highlight the need for additional investigations to elucidate the potential for upper airway obstruction when benzodiazepines and opioids are co-administered. CLINICAL TRIAL REGISTRATION: NCT04310579.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

OxycodoneMidazolamAnalgesics, OpioidHypnotics and SedativesRespirationHumansMaleDouble-Blind MethodCross-Over StudiesFemaleAdultYoung AdultHealthy VolunteersCarbon DioxideMiddle Aged

Stichwörter der Autor:innen

benzodiazepinesbreathingopioidspharmacodynamicspharmacokineticsrespiratory depression

Substanzen

OxycodoneMidazolamAnalgesics, OpioidHypnotics and SedativesCarbon Dioxide

Autor:innen und Institutionen

  • Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA.
  • Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands.
  • Division of Psychiatry, Office of Neuroscience, Office of New Drugs, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, MD, USA.
  • Division of Applied Regulatory Science, Office of Clinical Pharmacology, Office of Translational Sciences, Center for Drug Evaluation and Research, US Food and Drug Administration, Silver Spring, MD, USA; Booz Allen Ham…
  • KCAS Bioanalytical Services, Shawnee, KS, USA.
  • Spaulding Clinical Research, West Bend, WI, USA.

Förderung

  • Oak Ridge Institute for Science and Education
  • US Food and Drug Administration

Zitieren

APA

Gershuny, V., Florian, J., van der Schrier, R., Davis, M. C., Salcedo, P., Wang, C., Burkhart, K., Prentice, K., Shah, A., Racz, R., Patel, V., Matta, M., Ismaiel, O., Boughner, R., Ford, K. A., Rouse, R., Stone, M., Sanabria, C., Dahan, A., & Strauss, D. G. (2025). Effect of midazolam co-administered with oxycodone on ventilation: a randomised clinical trial in healthy volunteers. British Journal of Anaesthesia. https://doi.org/10.1016/j.bja.2024.11.047

Vancouver

Gershuny V, Florian J, van der Schrier R, Davis MC, Salcedo P, Wang C, et al. Effect of midazolam co-administered with oxycodone on ventilation: a randomised clinical trial in healthy volunteers. British Journal of Anaesthesia. 2025. doi:10.1016/j.bja.2024.11.047

BibTeX
@article{Gershuny2025,
  author = {Gershuny, Victoria and Florian, Jeffry and van der Schrier, Rutger and Davis, Michael C and Salcedo, Pablo and Wang, Celine and Burkhart, Keith and Prentice, Kristin and Shah, Aanchal and Racz, Rebecca and Patel, Vikram and Matta, Murali and Ismaiel, Omnia and Boughner, Rodney and Ford, Kevin A and Rouse, Rodney and Stone, Marc and Sanabria, Carlos and Dahan, Albert and Strauss, David G},
  title = {Effect of midazolam co-administered with oxycodone on ventilation: a randomised clinical trial in healthy volunteers},
  journal = {British Journal of Anaesthesia},
  year = {2025},
  doi = {10.1016/j.bja.2024.11.047}
}
Kostenlos starten →